Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ayala Pharmaceuticals, Inc. (AYLA) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ayala Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1797336.
Total stock buying since 2020: $23,628,696.
Total stock sales since 2020: $1,028,366.
Total stock option exercises since 2020: $30,960.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 59,998 | $1,028,366 | 6,000 | $30,960 |
| 2020 | 1,575,250 | $23,628,696 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-02 | 0 | $0 | 36,126 | $669,600 | 3,000 | $15,480 |
| 2021-01 | 0 | $0 | 23,872 | $358,766 | 3,000 | $15,480 |
| 2020-12 | 4 | $46 | 0 | $0 | 0 | $0 |
| 2020-09 | 11 | $110 | 0 | $0 | 0 | $0 |
| 2020-08 | 5 | $55 | 0 | $0 | 0 | $0 |
| 2020-07 | 5 | $56 | 0 | $0 | 0 | $0 |
| 2020-05 | 1,575,225 | $23,628,429 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-24 | Gordon Gary B. (Chief Medical Officer) | Sale | 3,000 | 17.46 | 52,386 |
| 2021-02-24 | Gordon Gary B. (Chief Medical Officer) | Option Ex | 3,000 | 5.16 | 15,480 |
| 2021-02-24 | Mamluk Roni (President & CEO) | Sale | 10,800 | 17.40 | 187,919 |
| 2021-02-23 | Mamluk Roni (President & CEO) | Sale | 7,126 | 17.89 | 127,484 |
| 2021-02-22 | Mamluk Roni (President & CEO) | Sale | 15,200 | 19.86 | 301,811 |
| 2021-01-21 | Mamluk Roni (President & CEO) | Sale | 1,406 | 15.04 | 21,147 |
| 2021-01-20 | Gordon Gary B. (Chief Medical Officer) | Sale | 3,000 | 15.03 | 45,084 |
| 2021-01-20 | Gordon Gary B. (Chief Medical Officer) | Option Ex | 3,000 | 5.16 | 15,480 |
| 2021-01-20 | Mamluk Roni (President & CEO) | Sale | 19,466 | 15.03 | 292,535 |
| 2020-12-23 | Sidransky David (Director) | Buy | 4 | 11.56 | 46 |
| 2020-09-14 | Sidransky David (Director) | Buy | 1 | 10.70 | 10 |
| 2020-09-11 | Sidransky David (Director) | Buy | 10 | 10.07 | 100 |
| 2020-08-14 | Sidransky David (Director) | Buy | 5 | 11.07 | 55 |
| 2020-07-17 | Sidransky David (Director) | Buy | 4 | 11.86 | 47 |
| 2020-07-07 | Sidransky David (Director) | Buy | 1 | 9.60 | 9 |
| 2020-05-12 | Amoon 2 Fund Limited Partnership (10% Owner) | Buy | 800,000 | 15.00 | 12,000,000 |
| 2020-05-12 | Israel Biotech Fund I, L.p. (10% Owner) | Buy | 225,000 | 15.00 | 3,375,000 |
| 2020-05-12 | Harel Insurance Investments & Financial Services Ltd. | Buy | 550,000 | 15.00 | 8,250,000 |
| 2020-05-12 | Sidransky David (Director) | Buy | 25 | 15.02 | 375 |
| 2020-05-08 | Sidransky David (Director) | Buy | 200 | 15.27 | 3,054 |
Insider trading activities including stock purchases, stock sales, and option exercises of AYLA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ayala Pharmaceuticals, Inc. (symbol AYLA, CIK number 1797336) see the Securities and Exchange Commission (SEC) website.